Free Trial

Neumora Therapeutics (NMRA) SEC Filings & 10K Form

$9.51
0.00 (0.00%)
(As of 05/29/2024 ET)

Recent Neumora Therapeutics SEC Filings

DateFilerForm TypeView
05/07/2024
6:15 AM
Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
4:00 PM
Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
5:46 AM
Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
3:34 PM
Neumora Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2024
6:08 AM
Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:20 PM
Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:21 PM
Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:13 PM
Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:14 PM
Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:15 PM
Gosebruch Henry O (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
7:32 AM
Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
6:52 PM
Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:52 PM
ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Fund VIII Overage, L.P. (Reporting)
ARCH Venture Fund X Overage, L.P. (Reporting)
ARCH Venture Fund X, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
ARCH Venture Partners VIII, LLC (Reporting)
ARCH Venture Partners X Overage, L.P. (Reporting)
ARCH Venture Partners X, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:53 PM
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
5:15 PM
Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/12/2023
5:16 PM
Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2023
3:21 PM
Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
5:54 PM
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
5:55 PM
Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
6:00 PM
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
6:01 PM
Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
5:59 PM
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
6:00 PM
Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
5:53 PM
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
5:55 PM
Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
7:18 PM
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
7:19 PM
Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
6:30 AM
AMGEN INC (Filed by)
Neumora Therapeutics (Subject)
Form SC 13D
09/25/2023
8:37 PM
Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2023
8:38 PM
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2023
7:30 AM
FMR LLC (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
5:15 AM
ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Fund VIII Overage, L.P. (Reporting)
ARCH Venture Fund X Overage, L.P. (Reporting)
ARCH Venture Fund X, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
ARCH Venture Partners VIII, LLC (Reporting)
ARCH Venture Partners X Overage, L.P. (Reporting)
ARCH Venture Partners X, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
5:16 AM
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
5:23 AM
Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
8:57 PM
Neumora Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/19/2023
8:47 PM
Gosebruch Henry O (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
6:52 PM
AMGEN INC (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
3:16 PM
Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
4:58 PM
Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
4:50 PM
Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
4:51 PM
Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Tech GIANT’s Plans to Revolutionize Crypto… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
09/18/2023
4:52 PM
Halawa Alaa (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
4:54 PM
Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
4:56 PM
Neumora Therapeutics (Issuer)
Piacquad David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
3:12 PM
Neumora Therapeutics (Filer)
Form 424B4
09/18/2023
2:11 PM
Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2023
11:15 PM
Neumora Therapeutics (Filer)
Form EFFECT
09/14/2023
8:22 PM
ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Fund VIII Overage, L.P. (Reporting)
ARCH Venture Fund X Overage, L.P. (Reporting)
ARCH Venture Fund X, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
ARCH Venture Partners VIII, LLC (Reporting)
ARCH Venture Partners X Overage, L.P. (Reporting)
ARCH Venture Partners X, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
8:29 PM
ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
7:56 PM
Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
5:52 PM
Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
5:57 PM
Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
5:58 PM
Gosebruch Henry O (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
5:58 PM
AMGEN INC (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
5:59 PM
BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
6:01 PM
FMR LLC (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
6:04 PM
Neumora Therapeutics (Issuer)
Suh Carol Y. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
6:05 PM
Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
6:06 PM
Neumora Therapeutics (Issuer)
Piacquad David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
6:06 PM
Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
6:07 PM
Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
6:08 PM
Halawa Alaa (Reporting)
Neumora Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
1:03 PM
Neumora Therapeutics (Filer)
Form CERT
09/13/2023
4:00 PM
Neumora Therapeutics (Filer)
Form 8-A12B
09/11/2023
5:07 AM
Neumora Therapeutics (Filer)
Form S-1/A
08/25/2023
4:03 PM
Neumora Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NMRA) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners